Showing results (1-10 of 137) with videos related to
Sort By:
Pageof 14
Internal and Emergency Medicine|July 22, 2026
Metabolic dysfunction-associated steatotic liver disease (MASLD): a growing global health priority and a real challenge for the internistMarcello PersicoExpert Review of Anti-Infective Therapy|May 26, 2011
Antiviral therapy: why does it fail in HCV-related chronic hepatitis?Mario Masarone, Marcello PersicoLiver International : Official Journal of the International Association for the Study of the Liver|April 16, 2019
Hepatitis C virus infection and non-hepatocellular malignancies in the DAA era: A systematic review and meta-analysisMario Masarone, Marcello PersicoWorld Journal of Gastroenterology|March 12, 2010
Steatosis as a co-factor in chronic liver diseasesMarcello Persico, Achille IolasconClinical Case Reports|October 31, 2014
A case of coffee-ground emesis in an elderly patientGiovanni D De Palma, Marcello Persico, Pietro ForestieriWorld Journal of Gastroenterology|August 9, 2021
Viral hepatitis: Milestones, unresolved issues, and future goalsPietro Torre, Andrea Aglitti, Mario Masarone, et al.Medical Hypotheses|September 10, 2013
Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pyloriLudovico Abenavoli, Natasa Milic, Mario Masarone, et al.Viruses|November 25, 2023
Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian ExperiencePietro Torre, Roberta Coppola, Mario Masarone, et al.Cancers|November 25, 2023
From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and PreventionBenedetta Maria Motta, Mario Masarone, Pietro Torre, et al.Reviews on Recent Clinical Trials|December 18, 2014
Non alcoholic fatty liver: epidemiology and natural historyMario Masarone, Alessandro Federico, Ludovico Abenavoli, et al.Pageof 14